1. Synthesis and Evaluation of Novel 2-Pyrrolidone-Fused (2-Oxoindolin-3-ylidene)methylpyrrole Derivatives as Potential Multi-Target Tyrosine Kinase Receptor Inhibitors
   Ting-Hsuan Yang et al, 2017, Molecules CrossRef
2. Treatment of Toxoplasmosis: An Insight on Epigenetic Drugs
   Paolo Guglielmi et al, 2022, Antiprotozoal Drug Development and Delivery CrossRef
3. PD-L1 Targeted Immunoliposomes with PD-L1 siRNA and HDAC Inhibitor for Anti-Lung Cancer Immunotherapy
   Se-Yun Hong et al, 2022, Biomedical Science Letters CrossRef
4. Antitumor effects of histone deacetylase inhibitor suberoylanilide hydroxamic acid in epidermal growth factor receptor-mutant non-small-cell lung cancer lines in vitro and in vivo
   Ye Wei et al, 2018, Anti-Cancer Drugs CrossRef
5. Epigenetic modulation by inorganic metal complexes
   Chung-Hang Leung et al, 2016, Coordination Chemistry Reviews CrossRef
6. Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells
   Tao Yan-Fang et al, 2015, PLOS ONE CrossRef
7. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways
   Igor Hrgovic et al, 2016, BMC Cancer CrossRef
8. Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells
   Münevver Yenigül et al, 2023, ACS Omega CrossRef
9. Epigenetic Targeting of Vascular Endothelial Growth Factor (VEGF) Receptors
   Steven G. Gray, 2019, Handbook of Nutrition, Diet, and Epigenetics CrossRef
10. Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study
    María Rodríguez-Remírez et al, 2020, Neuroendocrinology CrossRef
11. CD3+CD4+and CD3+CD8+Lymphocyte Subgroups and their Surface Receptors NKG2D and NKG2A in Patients with Non-small Cell Lung Cancer
    Da-Ping Yu et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
12. Histone deacetylase inhibitors as sanguine epitherapeutics against the deadliest lung cancer
    Shabir Ahmad Ganai et al, 2023, Epigenetic Regulation of Cancer in Response to Chemotherapy CrossRef
13. Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells
    KOJI YAMANEGI et al, 2015, International Journal of Oncology CrossRef
14. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells
    Tuan Hiep Tran et al, 2016, Archives of Pharmacal Research CrossRef
15. α-Viniferin-Induced Apoptosis through Downregulation of SIRT1 in Non-Small Cell Lung Cancer Cells
    Cheng Huang et al, 2023, Pharmaceuticals CrossRef
16. Design and Synthesis of C3‐Substituted β‐Carboline‐Based Histone Deacetylase Inhibitors with Potent Antitumor Activities
    Yong Ling et al, 2017, ChemMedChem CrossRef
17. Epigenetic Targeting of Vascular Endothelial Growth Factor (VEGF) Receptors
    Steven G. Gray, 2017, Handbook of Nutrition, Diet, and Epigenetics CrossRef
18. Vorinostat enhances the therapeutic potential of Erlotinib via MAPK in lung cancer cells
    Amany I Alqosaibi et al, 2022, Cancer Treatment and Research Communications CrossRef
19. The Effect of Organoselenium Compounds on Histone Deacetylase Inhibition and Their Potential for Cancer Therapy
    Theolan Adimulam et al, 2021, International Journal of Molecular Sciences CrossRef
20. Antioxidant and anticancer activity of synthesized 4-amino-5-((aryl substituted)-4H-1,2,4-triazole-3-yl)thio-linked hydroxamic acid derivatives
    Mousumi Das et al, 2019, Journal of Pharmacy and Pharmacology CrossRef
21. The Histone Deacetylase Inhibitor JAHA Down-Regulates pERK and Global DNA Methylation in MDA-MB231 Breast Cancer Cells
    Mariangela Librizzi et al, 2015, Materials CrossRef
22. Structural optimization and evaluation of novel 2-pyrrolidone-fused (2-oxoindolin-3-ylidene)methylpyrrole derivatives as potential VEGFR-2/PDGFRβ inhibitors
    Ting-Hsuan Yang et al, 2017, Chemistry Central Journal CrossRef
23. Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer
    Zohaib Rana et al, 2020, Biomedicines CrossRef
24. Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non–Small Cell Lung Cancer
    Dennis O. Adeegbe et al, 2017, Cancer Discovery CrossRef
25. Cardiomyogenic Differentiation Potential of Human Dilated Myocardium-Derived Mesenchymal Stem/Stromal Cells: The Impact of HDAC Inhibitor SAHA and Biomimetic Matrices
    Rokas Miksiunas et al, 2021, International Journal of Molecular Sciences CrossRef